Company Filing History:
Years Active: 2013-2017
Title: Innovations of Inventor MengFen Ho
Introduction
MengFen Ho is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important medicinal compounds. With a total of 3 patents to his name, his work has garnered attention for its efficiency and innovation.
Latest Patents
One of MengFen Ho's latest patents is titled "Process for preparing ibrutinib and its intermediates." This invention provides efficient, economical, and improved methods for synthesizing ibrutinib and its intermediates. The unique biphasic acylation reaction system described in the patent allows for easy separation of ibrutinib from the reaction mixture without additional extraction and wash steps. The isolated ibrutinib can be useful in the preparation of an amorphous form of the drug. In some embodiments, the isolated ibrutinib produced is a homogeneous solution of ibrutinib and DMSO, which may be directly used in the formation of the amorphous polymorph. Additionally, the solid form of ibrutinib can also be utilized in the formation of amorphous ibrutinib.
Another significant patent involves the "Crystalline forms of cabazitaxel." This invention provides crystalline forms, including an anhydrate form, of cabazitaxel and processes for their preparation. The patent designates these forms as C1, C2, C3, C4, C5, C6, C7, C8, C8b, C9, and C9p.
Career Highlights
MengFen Ho is currently associated with Scinopharm Taiwan, Ltd., where he continues to innovate in the field of pharmaceutical development. His work has not only advanced the synthesis of critical drugs but has also contributed to the overall efficiency of pharmaceutical manufacturing processes.
Collaborations
MengFen Ho has collaborated with notable colleagues such as YuanChang Huang and Julian Paul Henschke. These collaborations have further enhanced the scope and impact of his research.
Conclusion
In summary, MengFen Ho is a distinguished inventor whose innovative approaches to drug synthesis have led to significant advancements in pharmaceutical chemistry. His contributions continue to influence the industry positively.